These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
523 related articles for article (PubMed ID: 28539329)
1. Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer. Dong Z; Zhang A; Liu S; Lu F; Guo Y; Zhang G; Xu F; Shi Y; Shen S; Liang J; Guo W Mol Cancer Res; 2017 Jul; 15(7):800-810. PubMed ID: 28539329 [TBL] [Abstract][Full Text] [Related]
2. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development. Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858 [TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma. Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086 [TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma. Dong Z; Liang X; Wu X; Kang X; Guo Y; Shen S; Liang J; Guo W Clin Exp Metastasis; 2019 Jun; 36(3):225-241. PubMed ID: 30915595 [TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma. Guo W; Dong Z; Shi Y; Liu S; Liang J; Guo Y; Guo X; Shen S; Shan B Dig Liver Dis; 2016 Aug; 48(8):961-9. PubMed ID: 27338851 [TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma. Guo W; Dong Z; Liu S; Qiao Y; Kuang G; Guo Y; Shen S; Liang J Mol Carcinog; 2017 Aug; 56(8):1924-1934. PubMed ID: 28345805 [TBL] [Abstract][Full Text] [Related]
7. Aberrant hypermethylation-mediated downregulation of antisense lncRNA ZNF667-AS1 and its sense gene ZNF667 correlate with progression and prognosis of esophageal squamous cell carcinoma. Dong Z; Li S; Wu X; Niu Y; Liang X; Yang L; Guo Y; Shen S; Liang J; Guo W Cell Death Dis; 2019 Dec; 10(12):930. PubMed ID: 31804468 [TBL] [Abstract][Full Text] [Related]
8. Downregulated MEG3 contributes to tumour progression and poor prognosis in oesophagal squamous cell carcinoma by interacting with miR-4261, downregulating DKK2 and activating the Wnt/β-catenin signalling. Ma J; Li TF; Han XW; Yuan HF Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1513-1523. PubMed ID: 30990378 [TBL] [Abstract][Full Text] [Related]
9. Methylation Mediated Downregulation of TOB1-AS1 and TOB1 Correlates with Malignant Progression and Poor Prognosis of Esophageal Squamous Cell Carcinoma. Dong Z; Zhang G; Lu J; Guo Y; Liang J; Shen S; Guo W Dig Dis Sci; 2023 Apr; 68(4):1316-1331. PubMed ID: 36002674 [TBL] [Abstract][Full Text] [Related]
10. Up-regulated miR-548k promotes esophageal squamous cell carcinoma progression via targeting long noncoding RNA-LET. Chen Z; Lin J; Wu S; Xu C; Chen F; Huang Z Exp Cell Res; 2018 Jan; 362(1):90-101. PubMed ID: 29126868 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA MEG3 induces cell apoptosis in esophageal cancer through endoplasmic reticulum stress. Huang ZL; Chen RP; Zhou XT; Zhan HL; Hu MM; Liu B; Wu GD; Wu LF Oncol Rep; 2017 May; 37(5):3093-3099. PubMed ID: 28405686 [TBL] [Abstract][Full Text] [Related]
12. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma. Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893 [TBL] [Abstract][Full Text] [Related]
13. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma. Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis. Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022 [TBL] [Abstract][Full Text] [Related]
15. Knockdown of lncRNAXLOC_001659 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells. Li FZ; Zang WQ World J Gastroenterol; 2019 Nov; 25(42):6299-6310. PubMed ID: 31754291 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of microRNA-1288 in oesophageal squamous cell carcinoma. Gopalan V; Islam F; Pillai S; Tang JC; Tong DK; Law S; Chan KW; Lam AK Exp Cell Res; 2016 Nov; 348(2):146-154. PubMed ID: 27658568 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating Notch signaling pathway in esophageal squamous cell cancer. Zhang Y; Jin X; Wang Z; Zhang X; Liu S; Liu G Cancer Biomark; 2017 Dec; 21(1):89-96. PubMed ID: 29081407 [TBL] [Abstract][Full Text] [Related]
18. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions. Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA, tissue differentiation-inducing nonprotein coding RNA is upregulated and promotes development of esophageal squamous cell carcinoma. Xu Y; Qiu M; Chen Y; Wang J; Xia W; Mao Q; Yang L; Li M; Jiang F; Xu L; Yin R Dis Esophagus; 2016 Nov; 29(8):950-958. PubMed ID: 26833746 [TBL] [Abstract][Full Text] [Related]
20. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus. Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]